$SOTK
SONO TEK CORP Stock $sotk

$sotk Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000117152024000208 Filed on May 23, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2024
Revenue	$5.031M	$4.768M	$19.70M
YoY Change	39.63%	30.37%	30.82%
Cost Of Revenue	$2.577M	$2.427M	$9.855M
YoY Change	41.12%	32.46%	33.07%
Gross Profit	$2.454M	$2.341M	$9.845M
YoY Change	38.11%	28.26%	28.65%
Gross Profit Margin	48.79%	49.1%	49.97%
Selling, General & Admin	$1.485M	$1.689M	$5.776M
YoY Change	22.46%	41.06%	19.85%
% of Gross Profit	60.49%	72.15%	58.68%
Research & Development	$731.4K	$664.1K	$2.886M
YoY Change	11.42%	9.54%	34.25%
% of Gross Profit	29.8%	28.37%	29.31%
Depreciation & Amortization	$158.5K	$168.8K	$597.2K
YoY Change	17.22%	16.73%	16.89%
% of Gross Profit	6.46%	7.21%	6.07%
Operating Expenses	$2.216M	$2.353M	$8.662M
YoY Change	18.59%	30.46%	24.29%
Operating Profit	$238.3K	-$12.28K	$1.182M
YoY Change	-360.12%	-157.38%	73.13%
Interest Expense	$153.0K	$151.1K	$562.1K
YoY Change	23.75%	83.29%	425.72%
% of Operating Profit	64.21%		47.54%
Other Income/Expense, Net
YoY Change
Pretax Income	$391.3K	$138.8K	$1.745M
YoY Change	1121.7%	33.68%	120.86%
Income Tax	$60.47K	-$17.78K	$303.1K
% Of Pretax Income	15.45%	-12.81%	17.37%
Net Earnings	$330.8K	$156.6K	$1.441M
YoY Change	519.43%	147.62%	126.68%
Net Earnings / Revenue	6.58%	3.29%	7.32%
Basic Earnings Per Share	$0.02		$0.09
Diluted Earnings Per Share	$0.02	$0.01	$0.09
COMMON SHARES
Basic Shares Outstanding	15.75M shares	15.75M shares	15.74M shares
Diluted Shares Outstanding	15.77M shares		15.77M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.15M	$11.85M	$11.85M
YoY Change	0.08%	3.51%	3.51%
Cash & Equivalents	$2.402M	$2.135M	$2.135M
Short-Term Investments	$9.749M	$9.711M	$9.711M
Other Short-Term Assets	$148.6K	$207.7K	$207.7K
YoY Change	-21.5%	-18.23%	-18.23%
Inventory	$5.479M	$5.222M	$5.222M
Prepaid Expenses
Receivables	$1.402M	$1.471M	$1.471M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$19.18M	$18.75M	$18.75M
YoY Change	11.34%	13.1%	13.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.959M	$2.832M	$3.082M
YoY Change	2.29%	7.89%	7.21%
Goodwill
YoY Change
Intangibles	$45.02K	$47.57K
YoY Change	-15.36%	-16.85%
Long-Term Investments
YoY Change
Other Assets	$1.369M	$1.256M	$1.256M
YoY Change	88.39%	88.27%	88.27%
Total Long-Term Assets	$4.373M	$4.386M	$4.386M
YoY Change	19.08%	21.85%	21.85%
TOTAL ASSETS
Total Short-Term Assets	$19.18M	$18.75M	$18.75M
Total Long-Term Assets	$4.373M	$4.386M	$4.386M
Total Assets	$23.55M	$23.13M	$23.13M
YoY Change	12.7%	14.66%	14.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.021M	$1.050M	$1.050M
YoY Change	9.33%	29.46%	29.46%
Accrued Expenses	$1.712M	$1.739M	$1.739M
YoY Change	27.81%	21.86%	21.86%
Deferred Revenue	$3.340M	$3.420M
YoY Change	-7.5%	20.49%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.690M	$6.624M	$6.624M
YoY Change	8.86%	21.36%	21.36%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.690M	$6.624M	$6.624M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$6.890M	$6.853M	$6.853M
YoY Change	11.78%	23.69%	23.69%
SHAREHOLDERS EQUITY
Retained Earnings	$6.682M	$6.351M
YoY Change	34.63%	29.36%
Common Stock	$157.5K	$157.5K
YoY Change	0.06%	0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.66M	$16.28M	$16.28M
YoY Change
Total Liabilities & Shareholders Equity	$23.55M	$23.13M	$23.13M
YoY Change	12.7%	14.66%	14.66%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	$330.8K	$156.6K	$1.441M
YoY Change	519.43%	147.62%	126.68%
Depreciation, Depletion And Amortization	$158.5K	$168.8K	$597.2K
YoY Change	17.22%	16.73%	16.89%
Cash From Operating Activities	$328.0K	-$278.5K	$1.164M
YoY Change	-60.4%	-184.26%	-12.16%
INVESTING ACTIVITIES
Capital Expenditures	$32.97K	$468.1K	$794.7K
YoY Change	-77.87%	228.84%	42.96%
Acquisitions
YoY Change
Other Investing Activities	-$27.77K	-$100.6K	-$1.589M
YoY Change	-110.65%	950.99%	-29.54%
Cash From Investing Activities	-$60.74K	-$568.7K	-$2.384M
YoY Change	-154.4%	274.34%	-15.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities	$328.0K	-278.5K	$1.164M
Cash From Investing Activities	-$60.74K	-568.7K	-$2.384M
Cash From Financing Activities
Net Change In Cash	$267.2K	-847.1K	-$1.220M
YoY Change	-71.56%	-574.43%	-17.91%
FREE CASH FLOW
Cash From Operating Activities	$328.0K	-$278.5K	$1.164M
Capital Expenditures	$32.97K	$468.1K	$794.7K
Free Cash Flow	$295.0K	-$746.6K	$369.2K
YoY Change	-56.56%	-496.83%	-52.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0000806172
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2024	sotk	Accounts Receivable Reserve AccountsReceivableReserve		usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-28
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	72065185	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15750880	shares
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	dei	Auditor Firm AuditorFirmId	688
CY2024	dei	Auditor Name AuditorName	Marcum LLP
CY2024	dei	Auditor Location AuditorLocation	East Hanover, NJ
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2134786	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3354601	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	9711351	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	8090000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12225	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12225	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1470711	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1633866	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	5221980	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3242909	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	207738	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	254046	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	18746566	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	16575422	usd
CY2024Q1	us-gaap	Land Land	250000	usd
CY2023Q1	us-gaap	Land Land	250000	usd
CY2024Q1	sotk	Buildings Equipment Furnishings And Leasehold Improvements Net BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet	2832156	usd
CY2023Q1	sotk	Buildings Equipment Furnishings And Leasehold Improvements Net BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet	2624996	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47566	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	57202	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1255977	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	667098	usd
CY2024Q1	us-gaap	Assets Assets	23132265	usd
CY2023Q1	us-gaap	Assets Assets	20174718	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1049742	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	810863	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1739478	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1427446	usd
CY2024Q1	sotk	Customer Deposits CustomerDeposits	3419706	usd
CY2023Q1	sotk	Customer Deposits CustomerDeposits	2838165	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	414807	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	381421	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6623733	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5457895	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	229534	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	82865	usd
CY2024Q1	us-gaap	Liabilities Liabilities	6853267	usd
CY2023Q1	us-gaap	Liabilities Liabilities	5540760	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15750880	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15750880	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15742073	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15742073	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	157509	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	157421	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9770387	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9566898	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6351102	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4909639	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	16278998	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	14633958	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23132265	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20174718	usd
CY2024	us-gaap	Revenues Revenues	19699886	usd
CY2023	us-gaap	Revenues Revenues	15058203	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	9855311	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	7406196	usd
CY2024	us-gaap	Gross Profit GrossProfit	9844575	usd
CY2023	us-gaap	Gross Profit GrossProfit	7652007	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2885773	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2149525	usd
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3695870	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3169730	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2080447	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1649761	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	8662090	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	6969016	usd
CY2023	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	140042	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	303117	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	154009	usd
CY2024	us-gaap	Profit Loss ProfitLoss	1441463	usd
CY2023	us-gaap	Profit Loss ProfitLoss	635905	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15743763	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15735451	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15774007	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15769499	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	13741313	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	256740	usd
CY2023	us-gaap	Profit Loss ProfitLoss	635905	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	14633958	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	203577	usd
CY2024	us-gaap	Profit Loss ProfitLoss	1441463	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	16278998	usd
CY2024	us-gaap	Profit Loss ProfitLoss	1441463	usd
CY2023	us-gaap	Profit Loss ProfitLoss	635905	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	597166	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	510868	usd
CY2024	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	203577	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	256740	usd
CY2023	sotk	Accounts Receivable Reserve AccountsReceivableReserve	43898	usd
CY2024	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	47875	usd
CY2023	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	4864	usd
CY2024	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	32360	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-33119	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-442210	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-512337	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-163155	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	497463	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2026946	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	874531	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-46308	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-69258	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	238879	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	126352	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	312032	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-376582	usd
CY2024	sotk	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	581541	usd
CY2023	sotk	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	1670197	usd
CY2024	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	33386	usd
CY2023	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	322547	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1163866	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1325039	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	794690	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	555867	usd
CY2024	sotk	Sale Of Marketable Securities SaleOfMarketableSecurities	20237051	usd
CY2023	sotk	Sale Of Marketable Securities SaleOfMarketableSecurities	14329159	usd
CY2024	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	21826042	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	16584288	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2383681	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2810996	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1219815	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1485957	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3354601	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4840558	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2134786	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3354601	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	712092	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	363590	usd
CY2024	us-gaap	Advertising Expense AdvertisingExpense	371000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	297500	usd
CY2024Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1819000	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	9711351	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	8090000	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	9711351	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	8090000	usd
CY2024Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16434	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18814	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	212861	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	202681	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	16000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P40Y
CY2024Q1	us-gaap	Land Land	250000	usd
CY2024	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	72000	usd
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_z4xezaCORxxc" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_zEK5rdj0YbNa">Management Estimates</span></i></b><i> - </i>The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i> </i></b></p>
CY2024	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2886000	usd
CY2023	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2149000	usd
CY2024Q1	sotk	Cash Deposits CashDeposits	3420000	usd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	72000	usd
CY2023Q1	sotk	Cash Deposits CashDeposits	2838000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	145000	usd
CY2023	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	145000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	253710	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	61690	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.46
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.53
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y11M8D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	44739	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.71
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	16973	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.77
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	30717	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.66
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	250759	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	133609	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.84
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.62
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M7D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	73193	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.02
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	19701	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.62
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	8709	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.20
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	295542	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	181376	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.99
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.89
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y14D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	167709	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	203577	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	256740	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	298000	usd
CY2024	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8807	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0282	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0439	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0282	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0402	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.5502	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.6248	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.5502	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.6201	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	2270567	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1868689	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1785952	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	613915	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1165461	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	760305	usd
CY2024Q1	us-gaap	Inventory Gross InventoryGross	5221980	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	3242909	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	380400	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	332525	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9722595	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8934703	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6890439	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6309707	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2832156	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2624996	usd
CY2024	us-gaap	Depreciation Depreciation	580732	usd
CY2023	us-gaap	Depreciation Depreciation	492055	usd
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	579757	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	352619	usd
CY2024Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	524875	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	500650	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	152547	usd
CY2024Q1	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	133771	usd
CY2023Q1	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	157927	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	74826	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	100921	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	273702	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	315329	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1739478	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1427446	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	716003	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	438263	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	123743	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	83525	usd
CY2024	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	839746	usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	521788	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-471396	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-321458	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-65233	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-46321	usd
CY2024	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-536629	usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-367779	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	303117	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	154009	usd
CY2024Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	91000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	76000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	3000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	3000	usd
CY2024Q1	sotk	Capitalized Rd Expenses Irc Section174 CapitalizedRdExpensesIrcSection174	985000	usd
CY2023Q1	sotk	Capitalized Rd Expenses Irc Section174 CapitalizedRdExpensesIrcSection174	441000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	177000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	147000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1256000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	667000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	230000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	83000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	230000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	83000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	1441463	usd
CY2023	us-gaap	Profit Loss ProfitLoss	635905	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15743763	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15735451	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	30244	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	34048	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15774007	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15769499	shares
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8822000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8254000	usd

Files In Submission

Name	View Source	Status
0001171520-24-000208-index-headers.html	Edgar Link	pending
0001171520-24-000208-index.html	Edgar Link	pending
0001171520-24-000208.txt	Edgar Link	pending
0001171520-24-000208-xbrl.zip	Edgar Link	pending
eps11317_sotk.htm	Edgar Link	pending
ex21.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
eps11317_sotk_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sotk-20240229.xsd	Edgar Link	pending
sotk-logo.jpg	Edgar Link	pending
sotk-20240229_def.xml	Edgar Link	unprocessable
sotk-20240229_cal.xml	Edgar Link	unprocessable
sotk-20240229_pre.xml	Edgar Link	unprocessable
sotk-20240229_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SOTK
SONO TEK CORP Stock $sotk

2024 Q2 Form 10-K Financial Statement

#000117152024000208 Filed on May 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SOTK SONO TEK CORP Stock $sotk

2024 Q2 Form 10-K Financial Statement

#000117152024000208 Filed on May 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SOTK
SONO TEK CORP Stock $sotk